- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tanvex BioPharma Inc (6541)
Tanvex BioPharma Inc stock price live, this page displays TW 6541 stock exchange data. View the 6541 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tanvex BioPharma Inc real time stock price chart below.
What Is the Tanvex BioPharma Inc Stock Price Today?
The Tanvex BioPharma Inc stock price today is 54.00.
What Is the Stock Symbol for Tanvex BioPharma Inc?
The stock symbol for Tanvex BioPharma Inc is ""6541.""
What Stock Exchange Does Tanvex BioPharma Inc Trade On?
Tanvex BioPharma Inc is listed and trades on the Taiwan stock exchange.
Is Tanvex BioPharma Inc a Good Stock to Buy?
Determining whether Tanvex BioPharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6541 quote. (ISIN: KYG8676P1037)
What Is the Tanvex BioPharma Inc Stock Price Today?
The Tanvex BioPharma Inc stock price today is 54.00.
What Is the Stock Symbol for Tanvex BioPharma Inc?
The stock symbol for Tanvex BioPharma Inc is ""6541.""
What Stock Exchange Does Tanvex BioPharma Inc Trade On?
Tanvex BioPharma Inc is listed and trades on the Taiwan stock exchange.
Is Tanvex BioPharma Inc a Good Stock to Buy?
Determining whether Tanvex BioPharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6541 quote. (ISIN: KYG8676P1037)
Taiwan
Currency in TWD
54.00
+0.80(+1.50%)
Closed·
Fair Value
An estimate of a Tanvex BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.40
54.50
52 wk Range
48.10
82.00
6541 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a Tanvex BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.4054.50
52 wk Range
48.1082.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6541 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tanvex BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Tanvex BioPharma Inc Company Profile
Tanvex BioPharma, Inc., a biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States. It focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. The company’s products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Compare 6541 to Peers and Sector
Metrics to compare | 6541 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6541PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.0x | −24.7x | −0.5x | |
PEG Ratio | −0.20 | 0.02 | 0.00 | |
Price/Book | 2.3x | 2.8x | 2.6x | |
Price / LTM Sales | 158.6x | 30.5x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.5% | |
Fair Value Upside | Unlock | −12.6% | 6.8% | Unlock |
Earnings
Latest Release
May 13, 2025
EPS / Forecast
-2.09 / --
Revenue / Forecast
49.86M / --
FAQ
What Stock Exchange Does Tanvex BioPharma Trade On?
Tanvex BioPharma is listed and trades on the Taiwan Stock Exchange stock exchange.
What Is the Stock Symbol for Tanvex BioPharma?
The stock symbol for Tanvex BioPharma is "6541."
What Is the Tanvex BioPharma Market Cap?
As of today, Tanvex BioPharma market cap is 12.71B.
What Is Tanvex BioPharma's Earnings Per Share (TTM)?
The Tanvex BioPharma EPS (TTM) is -8.06.
When Is the Next Tanvex BioPharma Earnings Date?
Tanvex BioPharma will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is 6541 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tanvex BioPharma Stock Split?
Tanvex BioPharma has split 5 times.
How Many Employees Does Tanvex BioPharma Have?
Tanvex BioPharma has 198 employees.
What is the current trading status of Tanvex BioPharma (6541)?
As of 09 Aug 2025, Tanvex BioPharma (6541) is trading at a price of 54.00, with a previous close of 71.20. The stock has fluctuated within a day range of 52.40 to 54.50, while its 52-week range spans from 48.10 to 82.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.